Skip to content

Augusta Life Sciences Belgium

Active Risk: moderate
Private limited companyfounded 2025active for 1 yearErembodegem-Dorp 86, 9320 Aalst, BelgiumKBO/BCE: BE 1028.944.128
Summary

The computed 12-month bankruptcy probability of Augusta Life Sciences Belgium is 3.5% (moderate). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 2 administrative register entries (see administrative flags). No annual accounts have been filed with the National Bank.

Augusta Life Sciences BelgiumActive

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
No accounts filed yet
Financial health
Bankruptcy probabilitywithin 12 months
3.5%
No score: no figures
Structure
Signalsraises riskFounded in 20252 ex-officio strike-offs in the KBO2 warning signals in 24 months (strike-off 2)Administrative warnings in the KBO publicationslowers riskNo annual accounts with figuresShow the evidence

Bankruptcy probability

Bankruptcy probability, 12 months
3.5% Moderate
0%0.5%1.5%4%10%≥ 25%

About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.9% (3,267 companies, NACE 46, without accounts)
Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · 2 ex-officio strike-offs in the KBO
KBO publications
raises risk · 2 warning signals in 24 months (strike-off 2)
Belgian Official Gazette
lowers risk · No annual accounts with figures
NBB · filings
raises risk · Administrative warnings in the KBO publications
2 publications by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or their withdrawal.
KBO publications
Publications
UBO non-compliance×2
  1. UBO non-complianceevent 07-07-2026
  2. Appointment: James Dimmick (director)Gazette deed
  3. Resignations & appointmentsPower of attorney

Key points

  • Founded 12 months agofounded 09-10-2025 12 months View
  • Board changedlatest change 29-05-2026 · 3 in office 2 joined · 1 left View
  • No annual accounts yetat the National Bank 0 filed View

By topic

Board & ownership

Board
3 members
  • Tim CARNEWALDirector
  • Florent NavarroDirector
  • James DimmickDirector
Go to Board & ownership

Timeline

Events
8
Since
2025
  1. 29-05-2026Resignation: Henrik Uffe Holst (director)
  2. 04-05-2026UBO non-compliance
  3. 23-02-2026Resignation: Alonso Declercq Alexander (director)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
09-10-2025
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
19
Who signs
Each director alone
Financial year
From 1 October to 30 September
Annual meeting
First Monday of February at 10:30
Purpose
“Handel in al haar vormen, met inbegrip van de vervaardiging, aankoop, verkoop…” (deed in Dutch)
Go to Articles of association

Key facts about Augusta Life Sciences Belgium

What is the company number of Augusta Life Sciences Belgium?
1028.944.128. In Belgium the VAT number is the company number with BE in front: BE 1028.944.128.
Where is Augusta Life Sciences Belgium based?
The registered office is at Erembodegem-Dorp 86, 9320 Aalst.Company details
What does Augusta Life Sciences Belgium do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Augusta Life Sciences Belgium?
Private limited company (BV).
When was Augusta Life Sciences Belgium founded?
On 09-10-2025.
Is Augusta Life Sciences Belgium still active?
Yes, Augusta Life Sciences Belgium is an active enterprise in the KBO register.

Companies related to Augusta Life Sciences Belgium

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.